Showing results (741-750 of 816) with videos related to

Sort By:
Pageof 82
Leukemia|June 4, 2014
Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantationR B Walter, B Gyurkocza, B E Storer, et al.
The New England Journal of Medicine|August 8, 1996
Bone marrow transplantation for sickle cell diseaseM C Walters, M Patience, W Leisenring, et al.
Annals of Internal Medicine|January 1, 1980
Marrow transplantation in thirty "untransfused" patients with severe aplastic anemiaR Storb, E D Thomas, C D Buckner, et al.
Blood|November 23, 2000
Polyclonal hematopoiesis with variable telomere shortening in human long-term allogeneic marrow graft recipientsG Mathioudakis, R Storb, P A McSweeney, et al.
Transplantation|May 1, 1983
Disordered salivary immunoglobulin secretion and sodium transport in human chronic graft-versus-host diseaseK T Izutsu, K M Sullivan, M M Schubert, et al.
Bone Marrow Transplantation|May 29, 2007
Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignanciesE Ozdemir, R M Saliba, R E Champlin, et al.
Blood|October 1, 1983
Antithoracic duct lymphocyte globulin therapy of severe aplastic anemiaB Camitta, R J O'Reilly, L Sensenbrenner, et al.
Leukemia|September 23, 2016
PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignanciesM H Qazilbash, E Wieder, P F Thall, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2000
Status of high-dose chemotherapy for breast cancer: a reviewY Nieto, R E Champlin, J R Wingard, et al.
Bone Marrow Transplantation|August 12, 2009
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCTS O Ciurea, R Saliba, G Rondon, et al.
Pageof 82